SILENCED · Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
Primary completion date changed from estimate of Dec 14, 2025 to Aug 12, 2026
Also in this update: Trial completed
University Hospital, Gentofte, CopenhagenPhase 1/2 NCT07171723 Registry history of NCT07171723 on ClinicalTrials.gov (opens the registry)